Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
When he first came to the community 40 years ago, Dr. Abie Chadderdon, a South Dakota native and U.S. Army veteran, made a ...
Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback